Regimens of High doses of vitamin K may prevent vitamin K deficiency in very preterm infants
A new trial found that when compared to 0.3mg IM vitamin K birth prophylaxis, 1mg and 0.5 mg doses resulted in high sufficiency on follow-up. The trial results were published in 'The journal of Pediatrics.'
Intramuscular administration of vitamin K to prevent vitamin K deficiency bleeding (VKDB) has been a standard of care for a long time. Researchers conducted Open labeled, parallel-group, randomized clinical trial to study the efficacy of three different vitamin K birth prophylaxis regimens in premature infants at a Tertiary neonatal care unit in India.
Eligible patients included very preterm infants born ≤ 32 weeks and very low birth weight infants born ≤1500g. Infants were randomized, and 25 babies were enrolled in each group to receive 1.0mg,0.5mg, or 0.3mg of vitamin K1 I.M. (intramuscular) at birth. Protein induced by vitamin K absence - II (PIVKA-II) levels were assessed on days 5 and 28 along with the frequency of death, bleeding manifestations, intraventricular hemorrhage, necrotizing enterocolitis, bilirubin levels, and duration of phototherapy. The primary outcome was a comparison of PIVKA-II levels on day 5 of life.
Results:
- All the 3 regimens resulted in a similar proportion of vitamin K subclinical sufficiency (PIVKA-II < 0.028 AU/ml) infants on day 5[p 0.347], with no significant difference in median (interquartile range) PIVKA-II levels.
| Vitamin K dosage | proportion of babies |
| 1 mg | 100% |
| 0.5mg | 91.7% |
| 0.3 mg | 91.7% |
- However, on day 28, there was a significant fall in the proportion of vitamin K-sufficient infants in the 0.3mg IM group compared to the 1.0mg or 0.5mg groups.
Vitamin K dosage | proportion of babies |
| 1 mg | 100% |
| 0.5 mg | 91.3% |
| 0.3 mg | 72.7% |
- The 1.0mg group had significantly higher bilirubin levels and duration of phototherapy.
- There were no statistically different clinical outcomes.
Take-home points:
- In a randomized controlled trial comparing prophylactic vitamin K doses in 75 very preterm or very low birth weight infants, those receiving 1 mg intramuscular vitamin K at birth had significantly lower rates of vitamin K deficiency at 28 days than those receiving 0.3 mg.
- No significant difference was found in rates of specific bleeding complications or mortality based on prophylactic vitamin K dosage
Further reading: Hunnali CR, Devi U, Kitchanan S, S G. Three different regimens for vitamin K birth prophylaxis in preterm infants: A randomized clinical trial [published online ahead of print, 2022 Nov 4]. J Pediatr. 2022;S0022-3476(22)00992-1. doi: 10.1016/j.jpeds.2022.10.031
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.